Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor
Yoshio Nakamura(Tokyo Institute of Technology), Toshio Ogihara(Osaka University), Yoshikage Yo(The University of Osaka), Iwao Kida(The University of Osaka), Shinichiro Hayashi(The University of Osaka), Hiroaki Nakano(Japan Association for Development of Community Medicine), Kazuo Yamada(RIKEN Center for Brain Science), Toshikazu Nakamura(The University of Osaka), Atsushi Moriguchi(The University of Osaka), Kunio Matsumoto(Kanazawa University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Ryuichi Morishita(The University of Osaka)
Cited by 195
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588